Kyiv Vitamin Plant
Kyiv Vitamin Plant is a Kyiv-based Ukrainian pharmaceutical manufacturer producing 220+ prescription drugs, OTC medicines, and dietary supplements across 15+ therapeutic categories, distributing through domestic pharmacies, national reimbursement programs, and representative offices in Moldova and Kazakhstan.
- Company typePrivate
- Founded1945
- HeadquartersKyiv, Ukraine
- Headcount501–1,000
- GTM typeB2B
- OfferingHardware or Manufacturing
What Kyiv Vitamin Plant does
Kyiv Vitamin Plant JSC is a Ukrainian pharmaceutical manufacturer headquartered in Kyiv that has operated continuously since the mid-1940s, producing over 220 pharmaceutical products spanning 15+ therapeutic categories — including vitamins and microelements, cardiology, neurology, gastroenterology, ophthalmology, urology, gynecology, rheumatology, dermatology, endocrinology, immunology/allergology, and psychiatry. The product mix combines proprietary developed formulations (e.g., AEvit, Askorbinka-KV across multiple flavors, Magnikor, Magnikum, Metafora) with in-licensed European products, supported by 5 in-house laboratories for quality control and product development and a workforce of 1,000+ employees.
The company operates a multi-channel go-to-market model: prescription and OTC products are distributed through Ukrainian pharmacy networks, eligible products are included in national programs ('National Cashback', 'Accessible Medicines'), and international expansion is executed through dedicated representative offices in Chișinău (Moldova) and Almaty (Kazakhstan). Inbound product portfolio growth is driven by in-licensing agreements with European pharmaceutical manufacturers (covering gynecology, urology, ophthalmology, dermatology and beyond), while outbound commercial growth is pursued through out-licensing of internally-developed products to international partners. Dedicated distribution and licensing managers (with named contact channels for distribution and inbound licensing) execute the partnership strategy.
Revenue mechanics are anchored in unit-priced pharmaceutical sales through pharmacies and reimbursement via Ukrainian national healthcare programs, with international offices generating incremental distribution and licensing revenue. The company is incorporated as a Joint-Stock Company under Ukrainian law, is not publicly listed, and reports no funding rounds or external investors in the source data. Custom
Kyiv Vitamin Plant firmographics
Firmographics- Name
- Kyiv Vitamin Plant
- Legal name
- Kyiv Vitamin Plant JSC
- Website
- https://vitamin.com.ua
- Company type
- Private
- Founded year
- 1945
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- Kyiv Vitamin Plant is a Kyiv-based Ukrainian pharmaceutical manufacturer producing 220+ prescription drugs, OTC medicines, and dietary supplements across 15+ therapeutic categories, distributing through domestic pharmacies, national reimbursement programs, and representative offices in Moldova and Kazakhstan.
- Ownership category
- akta.pro rank
Kyiv Vitamin Plant industry classification
Industry- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Medicinal and Botanical Manufacturing (325411), Pharmaceutical and Medicine Manufacturing (3254)
- SIC
- Pharmaceutical Preparations (2834), Medicinal Chemicals & Botanical Products (2833)
- akta.pro primary industry
- Vitamins (A, B-Complex, C, D, E, K; Premixes) (AFAJAKAA)
- akta.pro secondary industries
- Vitamins & Minerals (Single Nutrients) (CRADAGAB), Multivitamins & Daily Packs (CRADAGAC), Herbal & Botanical Supplements (CRADAGAD)
Keywords
Where Kyiv Vitamin Plant is headquartered
LocationHeadquarters
- HQ city
- Kyiv
- HQ country
- Ukraine
- HQ region
- Europe
Offices3 records
Markets served
Kyiv Vitamin Plant business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Infrastructure, Technology or R&D, Marketing or Sales
Revenue model
- Pharmaceutical Product Sales: Manufacturing and selling pharmaceutical products including prescription drugs, over-the-counter medicines, dietary supplements, and medical devices through pharmacies and healthcare providers
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Over-the-counter pharmaceutical products |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels5 records
Kyiv Vitamin Plant product offering
Product offeringCore offering
Kyiv Vitamin Plant JSC is a Ukrainian pharmaceutical manufacturer that produces over 220 medicines, dietary supplements, and medical devices across 15+ therapeutic categories, including cardiology, neurology, gastroenterology, endocrinology, gynecology, ophthalmology, and immunology. The company manufactures both prescription drugs and over-the-counter products, operates 5 in-house laboratories, and sells through pharmacy networks, national healthcare programs, and international representative offices in Moldova and Kazakhstan.
Product overview
Kyiv Vitamin Plant JSC is a national pharmaceutical manufacturing company offering over 220 pharmaceutical products including prescription drugs, over-the-counter medications, dietary supplements, and medical devices. The product portfolio spans multiple therapeutic categories including vitamins and microelements (AEvit, Askorbinka-KV in various flavors, Vitamin A, Vitamin E, Magnikum), ophthalmology, urology, gynecology (Femiklin), rheumatology, cardiology (Magnikor, Korvalment, Normoven), neurology (Aminalon-KV, Glutamic acid, Relaksil), gastroenterology (Artihol, Afletin, Bionorm Detoks), endocrinology (Metafora, Iod-normil), dermatology, parasitology, psychiatry, pediatrics, and immunology/allergology (Imunoplus, Ergo cetal). The company operates through in-licensing partnerships with European manufacturers and maintains 5 own laboratories for quality control and research.
Differentiator
Problem solved
Functional benefit
Quantifiable outcome
- Over 220 pharmaceutical products in portfolio
- +1 more outcomes
Companies that use Kyiv Vitamin Plant
Customer profileNamed customers1 record
Segments2 records
Ideal customer profiles3 records
Kyiv Vitamin Plant technology and API
TechnologyAPI detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
Kyiv Vitamin Plant partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- European Pharmaceutical ManufacturerscoreKyiv Vitamin Plant pursues in-licensing partnerships with leading European manufacturers to expand its product portfolio with generic and innovative pharmaceutical products as well as medical devices in areas such as gynecology, urology, ophthalmology, and dermatology.
Scale indicators4 records
Recent moves5 records
Expansion highlights5 records
Kyiv Vitamin Plant competitors and assessment
Company assessmentDirect peers
- Arterium: Ukrainian pharmaceutical group combining Kyiv-based manufacturing with international brands (e.g., Halychpharm). Comparable as a domestic multi-therapeutic manufacturer with overlapping generic/vitamin exposure.
- Farmak: Ukraine's largest pharmaceutical manufacturer headquartered in Kyiv, producing a broad portfolio of finished dosage forms across multiple therapeutic areas. Highly comparable as a domestic Ukrainian pharma peer competing for the same reimbursement channels and pharmacy shelf space.
- Darnitsa Pharmaceutical Firm: Major Kyiv-based Ukrainian generic pharmaceutical manufacturer with a wide therapeutic portfolio. Directly comparable in product mix, customer base (Ukrainian pharmacies and healthcare programs), and channel dynamics.
Broad incumbents
- Polpharma: Polish generic pharmaceutical manufacturer with strong presence in CEE markets. Comparable as a competing generic supplier targeting similar therapy areas and Eastern European pharmacy/distribution channels.
- Teva Pharmaceutical Industries: Global generic pharmaceutical leader with extensive CEE/CIS footprint. Comparable as a large-scale generic manufacturer competing across the same therapy areas and seeking the same regional pharmacy and government channels.
- KRKA: Slovenian-headquartered generic pharmaceutical manufacturer with strong CEE/CIS presence, including Ukraine. Comparable as a competing generic supplier in the same regional markets and reimbursement channels.
- Gedeon Richter: Hungary-headquartered multinational pharmaceutical company with significant CEE/CIS operations including Ukraine. Comparable as an established regional player whose portfolio overlaps with Kyiv Vitamin Plant's therapeutic categories.
- Stada Arzneimittel: Germany-headquartered generics and consumer healthcare company with broad CEE presence. Comparable as a competing European-headquartered generic manufacturer with overlapping vitamin/OTC positioning.
- Sopharma: Bulgarian pharmaceutical manufacturer with broad generic and OTC portfolio across CEE markets. Comparable as a regional generic/OTC manufacturer with overlapping therapeutic categories and Eastern European distribution footprint.
Regional players
- Indar: Kyiv-based Ukrainian manufacturer specializing in insulin and biological preparations. Comparable as a domestic Ukrainian pharma peer operating under similar regulatory and reimbursement frameworks, though focused on a narrower therapeutic niche.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Kyiv Vitamin Plant social profiles
Digital presenceKyiv Vitamin Plant financial estimates
Financial estimateRevenue estimate
Valuation estimate
Kyiv Vitamin Plant leadership team
Management profileNumber of profiles
Kyiv Vitamin Plant funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Kyiv Vitamin Plant M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Kyiv Vitamin Plant
What does Kyiv Vitamin Plant do?
Kyiv Vitamin Plant JSC is a Ukrainian pharmaceutical manufacturer that produces over 220 medicines, dietary supplements, and medical devices across 15+ therapeutic categories, including cardiology, neurology, gastroenterology, endocrinology, gynecology, ophthalmology, and immunology. The company manufactures both prescription drugs and over-the-counter products, operates 5 in-house laboratories, and sells through pharmacy networks, national healthcare programs, and international representative offices in Moldova and Kazakhstan.
Is Kyiv Vitamin Plant a public or private company?
Kyiv Vitamin Plant is a private company. It is currently operating.
When was Kyiv Vitamin Plant founded?
Kyiv Vitamin Plant was founded in 1945. It employs 501 to 1,000 people.
Where is Kyiv Vitamin Plant based?
Kyiv Vitamin Plant is headquartered in Kyiv, Ukraine, in the Europe region.
How does Kyiv Vitamin Plant make money?
One revenue line is on record: pharmaceutical Product Sales.
Who are Kyiv Vitamin Plant's main competitors?
Direct peers on record are Arterium, Farmak and Darnitsa Pharmaceutical Firm. Broad incumbents are Polpharma, Teva Pharmaceutical Industries, KRKA, Gedeon Richter, Stada Arzneimittel and Sopharma. Indar is listed as a regional player.
Does Kyiv Vitamin Plant have an API?
No public API is recorded for Kyiv Vitamin Plant.
What industry is Kyiv Vitamin Plant in?
Its primary akta.pro industry code is AFAJAKAA, Vitamins (A, B-Complex, C, D, E, K; Premixes), with a secondary code of CRADAGAB, Vitamins & Minerals (Single Nutrients). Its NAICS code is 325412 and its SIC code is 2834.